GLP-1 medications are primarily used for two medical purposes: To improve blood sugar control in people with type 2 diabetes To support long-term weight loss in individuals with overweight or obesity, especially those who have weight-related health conditions Some formulations, such as Ozempic and Rybelsus, are approved by the U.S
Rotate injection sites, use correct technique, and maintain cleanliness
These numbers are increasing, with studies supporting that people with asthma are 75% more likely to become obese than those without asthma
Retrieved from Elahi Vahed, I., Shahir-Roudi, E., Nojumi, S., et al
Start your intake How Semaglutide Works for Modest Weight Loss Targets Semaglutide reduces appetite by activating GLP-1 receptors in your brain that signal fullness and decrease hunger hormones like ghrelin
For example, glucose-stimulated GLP-1 release requires sodium/glucose cotransporter-1 induction of inward currents, initiating depolarization of EECs and calcium influx to release GLP-1 103,104,105